Drugs Made In America Acquisition Corp. (DMAAU) Total Current Liabilities (2024 - 2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Total Current Liabilities came in at $376172.0 in Q4 2025, down 52.72% YoY from $795669.0 in Q4 2024, and down 17.62% on a QoQ basis from $456611.0 in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Total Current Liabilities (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 2 years of Total Current Liabilities data on file, last reported at $376172.0 in Q4 2025.
- Quarterly Total Current Liabilities fell 52.72% year-over-year to $376172.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $376172.0 (down 52.72% YoY) and the FY2025 annual result came in at $376172.0, down 52.72% from the prior year.
- Total Current Liabilities slipped to $376172.0 in Q4 2025, from $456611.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $795669.0 in Q4 2024 to a low of $301441.0 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 376,172.00 |
| Sep 30, 2025 | 456,611.00 |
| Jun 30, 2025 | 301,441.00 |
| Mar 31, 2025 | 347,369.00 |
| Dec 31, 2024 | 795,669.00 |